Literature DB >> 20431741

Gastroparesis: current concepts and management.

Tatsuhiro Masaoka1, Jan Tack.   

Abstract

Delayed gastric emptying in the absence of mechanical obstruction is referred to as gastroparesis. Symptoms that are often attributed to gastroparesis include postprandial fullness, nausea, and vomiting. Although tests of gastric motor function may aid diagnostic labeling, their contribution to determining the treatment approach is often limited. Although clinical suspicion of gastroparesis warrants the exclusion of mechanical causes and serum electrolyte imbalances, followed by empirical treatment with a gastroprokinetic such as domperidone or metoclopramide, evidence that these drugs are effective for patients with gastroparesis is far from overwhelming. In refractory cases with severe weight loss, invasive therapeutics such as inserting a feeding jejunostomy tube, intrapyloric injection of botulinum toxin, surgical (partial) gastrectomy, and implantable gastric electrical stimulation are occasionally considered.

Entities:  

Keywords:  Delayed gastric emptying; Diabetes mellitus; Gastric electrical stimulation; Gastroparesis; Prokinetic therapy

Year:  2009        PMID: 20431741      PMCID: PMC2852706          DOI: 10.5009/gnl.2009.3.3.166

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  63 in total

1.  Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.

Authors:  D L Dumitrascu; M Weinbeck
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

2.  Gastric electrical stimulation in medically refractory nausea and vomiting.

Authors:  Guillaume Gourcerol; Isabelle Leblanc; Anne Marie Leroi; Philippe Denis; Philippe Ducrotte
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 2.566

3.  The difficult patient with gastroparesis.

Authors:  Jan Tack
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

4.  Gastric electrical stimulation for the treatment of gastroparesis: ready for prime time?

Authors:  D Ang; J Tack
Journal:  Digestion       Date:  2007-05-18       Impact factor: 3.216

Review 5.  Treatment of gastroparesis: a multidisciplinary clinical review.

Authors:  T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

Review 6.  Gastric motor disorders.

Authors:  J Tack
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

7.  Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.

Authors:  J Arts; S van Gool; P Caenepeel; K Verbeke; J Janssens; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2006-08-15       Impact factor: 8.171

8.  Botulinum toxin A for the treatment of delayed gastric emptying.

Authors:  Frank K Friedenberg; Amiya Palit; Henry P Parkman; Alexandra Hanlon; Deborah B Nelson
Journal:  Am J Gastroenterol       Date:  2007-12-05       Impact factor: 10.864

9.  Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.

Authors:  J Arts; L Holvoet; P Caenepeel; R Bisschops; D Sifrim; K Verbeke; J Janssens; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2007-11-01       Impact factor: 8.171

Review 10.  Prokinetics and fundic relaxants in upper functional GI disorders.

Authors:  Jan Tack
Journal:  Curr Opin Pharmacol       Date:  2008-10-27       Impact factor: 5.547

View more
  10 in total

1.  Botulinum toxin A as a treatment for delayed gastric emptying in a dog.

Authors:  Max L Rinaldi; Boel A Fransson; Sabrina L Barry
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  Radiofrequency catheter ablation-induced gastroparesis successfully treated with administration of mosapride citrate: two case reports.

Authors:  Naotaka Ogasawara; Yoshiharu Yamaguchi; Takuya Takahama; Kazunori Adachi; Manami Suzuki; Shinya Izawa; Masahide Ebi; Yasushi Funaki; Makoto Sasaki; Kunio Kasugai
Journal:  Clin J Gastroenterol       Date:  2019-08-27

3.  Enteric Glial Dysfunction Evoked by Apolipoprotein E Deficiency Contributes to Delayed Gastric Emptying.

Authors:  Seiichiro Fukuhara; Tatsuhiro Masaoka; Soraya Nishimura; Masaya Nakamura; Juntaro Matsuzaki; Hitoshi Tsugawa; Sawako Miyoshi; Hideki Mori; Satoshi Kawase; Shinsuke Shibata; Hideyuki Okano; Takanori Kanai; Hidekazu Suzuki
Journal:  Dig Dis Sci       Date:  2017-11-02       Impact factor: 3.199

4.  Itraconazole and domperidone: a placebo-controlled drug interaction study.

Authors:  Tsuneaki Yoshizato; Tsutomu Kotegawa; Hiromitsu Imai; Kimiko Tsutsumi; Junko Imanaga; Tetsuji Ohyama; Kyoichi Ohashi
Journal:  Eur J Clin Pharmacol       Date:  2012-03-15       Impact factor: 2.953

5.  Management of gastroparesis: beyond basics.

Authors:  Jan Tack; Christophe Vanormelingen
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

Review 6.  Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.

Authors:  Sheena K Aurora; Spyridon Papapetropoulos; Shashidhar H Kori; Archana Kedar; Thomas L Abell
Journal:  Cephalalgia       Date:  2013-03-05       Impact factor: 6.292

7.  A Case of Gastroparesis after Cryoballoon Ablation followed by Medication-Induced Recovery within 6 Months.

Authors:  Yukie Sunata; Hideki Mori; Yuichiro Hirai; Yoko Kubosawa; Shigeo Banno; Satoshi Kinoshita; Yoshihiro Nakazato; Toshihiro Nishizawa; Masahiro Kikuchi; Toshio Uraoka
Journal:  Case Rep Gastroenterol       Date:  2018-08-23

8.  Gastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors.

Authors:  Yousef Nassar; Seth Richter
Journal:  Gastroenterology Res       Date:  2018-10-01

Review 9.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

10.  Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor.

Authors:  Chunlin Chen; Wenwen Zhang; Muhammad Bari; Cristina Almansa; Mike Baratta; Maria Rosario
Journal:  Clin Pharmacol       Date:  2021-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.